Therefore, NF-κB, as well as its downstream or upstream signaling effectors, may be effective molecular targets for the detection or inhibition of SCCHN hematologic and lymphatic metastasis. The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.